CochLear Ltd. Unsponsored ADR (OTCMKTS:CHEOY – Get Free Report) was down 4.7% on Monday . The company traded as low as $60.00 and last traded at $60.38. Approximately 6,612 shares traded hands during mid-day trading, a decline of 81% from the average daily volume of 34,139 shares. The stock had previously closed at $63.34.
Analysts Set New Price Targets
Separately, Royal Bank Of Canada raised CochLear from a “hold” rating to a “moderate buy” rating in a report on Monday, January 19th. Two investment analysts have rated the stock with a Strong Buy rating, one has issued a Buy rating and two have issued a Hold rating to the company. According to MarketBeat.com, CochLear currently has an average rating of “Buy”.
Read Our Latest Analysis on CHEOY
CochLear Stock Up 0.5%
CochLear Company Profile
Cochlear Limited provides implantable hearing solutions for children and adults worldwide. It offers cochlear implant systems, sound processor upgrades, bone conduction systems, accessories, and other products. Cochlear Limited was founded in 1981 and is headquartered in Sydney, Australia.
Featured Stories
- Five stocks we like better than CochLear
- The “secret weapon” behind Microsoft, Meta, Amazon, and Google
- A personal warning from Martin Weiss (Please read)
- Elon Musk: This Could Turn $100 into $100,000
- ~$1.5T SpaceX IPO: Pre-IPO Opportunity
- Iran isn’t the real war
Receive News & Ratings for CochLear Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CochLear and related companies with MarketBeat.com's FREE daily email newsletter.
